+852 2866 8995 General Enquiry: cs@medikonia.com | Support: support@medikonia.com

PneumaCult™-ALI-S Medium

Serum- and BPE-free medium for human small airway epithelial cells cultured at the air-liquid interface

Product description Order information Resources Panel

Overview

PneumaCult™-ALI-S Medium (Catalog #05050) is a serum- and BPE-free medium for the culture of human small airway epithelial cells at the air-liquid interface (ALI). Small airway epithelial cells cultured in PneumaCult™-ALI-S Medium undergo extensive mucociliary differentiation to form a cuboidal epithelium that exhibits morphological and functional characteristics similar to those of the human small airway in vivo.

Together, PneumaCult™-ALI-S Medium and PneumaCult™-Ex Plus Medium (#05040) constitute a fully integrated BPE-free culture system for in vitro human small airway modeling. This robust and defined system is a valuable tool for basic respiratory research, toxicity studies, and drug development.

 

Subtype
Specialized Media
 

Cell Type
Airway Cells
 

Species
Human
 

Application
Cell Culture, Differentiation, Maintenance
 

Brand
PneumaCult
 

Area of Interest
Disease Modeling, Drug Discovery and Toxicity Testing, Epithelial Cell Biology, Respiratory Research
 

Formulation Category
Serum-Free

 

Product Advantages

- Human small airway epithelial cells (HSAEC) cultured in PneumaCult™-ALI-S undergo extensive mucociliary differentiation to form a cuboidal epithelium that closely resembles the small airway epithelium

- PneumaCult™-ALI-S is serum-free and BPE-free to minimize variability

- PneumaCult™-ALI-S and PneumaCult™-Ex Plus constitute a complete, optimized system for expansion, maintenance, and differentiation of HSAEC

 

What's Included

- PneumaCult™-ALI-S Basal Medium, 450 mL

- PneumaCult™-ALI-S Supplement (10X), 50 mL

- PneumaCult™-ALI-S Maintenance Supplement (100X), 5 x 1 mL

Catalog #: 05050

Please email us at cs@medikonia.com for any enquiry. To place an order, please include the catalog number(s) of the product(s) in the email.